A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health benefits The GuardianWhy Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s CNBCPeople with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug NBC NewsEli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial STAT